(2007). Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ Publishing Group Ltd.
Chicago ZitierstilModelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Publishing Group Ltd, 2007.
MLA ZitierstilModelling the Cost Effectiveness of Interferon Beta and Glatiramer Acetate in the Management of Multiple Sclerosis. BMJ Publishing Group Ltd, 2007.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.